LAURA A KING
Allopathic & Osteopathic Physicians|Dermatology LOS ALAMITOS, CA NPI 1487623948
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology CA Amgen Inc. All categories
General Payments — all program years on this page
$2,272.47
- Category: General Payments
- Program years: PY2018–2024
- Record count: 97
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $462.95 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $462.95 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $333.14 | 5 |
| Galderma Laboratories, L.P. | $62.13 | 1 |
| PFIZER INC. | $28.63 | 1 |
| REVANCE THERAPEUTICS, INC. | $20.37 | 1 |
| Organon LLC | $18.68 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1117298014 | Amgen Inc. | $7.59 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117298016 | Amgen Inc. | $149.11 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117298018 | Amgen Inc. | $7.21 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117298020 | Amgen Inc. | $149.11 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117298022 | Amgen Inc. | $20.12 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131417120 | PFIZER INC. | $28.63 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136313413 | Organon Llc | $18.68 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145309294 | Galderma Laboratories, L.P. | $62.13 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147921884 | REVANCE THERAPEUTICS, INC. | $20.37 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.